Nemo coiled coil mimics and methods of using same
AssigneeNew York University
InventorsParamjit S. ARORA, Michael G. WUO
Life of this patent
Estimating the term…
Abstract
This invention relates to macrostructures (and pharmaceutical formulations containing them) that include a parallel coiled-coil structure, wherein the parallel coiled-coil comprises a first coil of Formula I and a second coil of Formula II: T1-f0-g0-a1-b1-c1-d1-e1-f1-g1-a2-b2-C2-d2-e2-f2-g2-a3-b3-c3-d3-e3-T2 (I) T3-g′0-a′1-b′1-c′1-d′1-e′1-f′1-g′1-a′2-b′2-c′2-d′2-f′2-g′2-a′3-b′3-c′3-d′3-f′3-T4 (II), as described in the present application. Methods of using these macrostructures are also disclosed.
Claims17
A macrostructure comprising a parallel coiled-coil, wherein the parallel coiled-coil comprises:
- a first coil of Formula I and a second coil of Formula II:
- (Formula I)
- (SEQ ID NO:
- 1)
- T1-f0-g0-a1-b1-c1-d1-e1-f1-g1-a2-b2-c2-d2-e2-f2-g2-a3-
- b3-c3-d3-e3-T2
- (Formula II)
- (SEQ ID NO:
- 2)
- T3-g′0-a′1-b′1-c′1-d′1-e′1-f′1-g′1-a′2-b′2-c′2-d′2-
- e′2-f′2-g′2-a′3-b′3-c′3-d′3-e′3-f′3-T4,
- wherein:
- each a1-3, b1-3, c1-3, d1-3, e1-3, f0-2, g0-2, a′1-3, b′1-3, c′1-3, d′1-3, e′1-3, f1-3, and g′0-2 is independently absent or a residue selected from the group consisting of modified or unmodified amino acid residues and analogues thereof;
- one or more of the following residue pairs are covalently bound by a linker:
- g0-e′1, g1-e′2, g2-e′3, d1-d′1, d2-d′2, d3-d′3, a1-a′1, a2-a′2, a3-a′3, e1-g′0, e2-g′1, and e3-g′2;
- each T1 and T3 is independently a point of attachment from a terminal nitrogen to one or more moieties, wherein each moiety is independently H, —PG1, —C(O)R, —C(O)NR2, —C(O)NH2, —R, —C(O)OR, an amino acid or analogue thereof, a peptide, a targeting moiety, or a tag, where PG1 is an amine protecting group and each R is independently hydrogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl, a heteroaryl, a heterocyclyl, an arylalkyl, a peptide, a targeting moiety, or a tag;
- and
- each T2 and T4 is independently a point of attachment from a terminal carbonyl to H, -OPG2, -NPG2, —OR, —OH, —NR2,—NH2, —N(R)C(O)C1-6 alkyl, -N(H)C(O)C1-6 alkyl, an amino acid or analogue thereof, a peptide, a targeting moiety, or a tag, where PG2 is a carboxylic acid protecting group and each R is independently hydrogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl, a heteroaryl, a heterocyclyl, an arylalkyl, a peptide, a targeting moiety, or a tag;
- and wherein:
- the first coil comprises at least fourteen contiguous residues, wherein the at least fourteen contiguous residues have the formula X1-X2-X3-X4_X5-X6-X7-X8-X9-X10-X11-X12-X13-X14;
- the second coil comprises at least fourteen contiguous residues, wherein the at least fourteen contiguous residues have the formula X′1—X′2—X′3—X′4-X's-X′6—X′7—X′8—X′9—X′10—X′11—X′12—X′13—X′14;
- and
- wherein each residue is selected from the groups indicated below (superscript letters indicate each residue's location within Formula I and Formula II;
- residues in the a, a′, d, d′, e, e′, g, and g′ positions can optionally be modified to facilitate attachment of a linker or replaced with a linker)
- First Coil
- Second Coil
- Preferred
- Preferred
- Residue
- Group
- Residue(s)
- Residue
- Group
- Residue(s)
- fX1
- any residue
- Val, Glu
- gX2
- modified or
- Trp
- gX′1
- any residue
- Ala, Glu,
- unmodified
- azidolysine,
- Trp and
- Cys
- analogues
- thereof
- aX3
- any
- Cys, HCys, Leu,
- aX′2
- any
- Cys, HCys, Leu,
- hydrophobic
- Ile, allylleucine,
- hydrophobic
- Ile, allylleucine,
- residue
- Val, allylglycine,
- residue
- Val, allylglycine,
- Thr,
- Thr,
- selenocysteine,
- selenocysteine,
- hexafluoroleucine,
- hexafluoroleucine,
- hexafluorovaline
- hexafluorovaline
- (or analogue of
- (or analogue of
- any of the
- any of the
- preceding
- preceding
- residues)
- residues)
- bX4
- any
- His, Arg
- bX′3
- modified or
- His
- positively
- unmodified
- charged
- His and
- residue
- analogues
- thereof
- cX5
- modified or
- Gln
- cX′4
- any
- Gln, Arg
- unmodified
- positively
- Gln and
- charged
- analogues
- residue,
- thereof
- modified or
- unmodified
- Gln and
- analogues
- thereof
- dX6
- any
- Cys, HCys, Leu,
- dX′5
- any
- Cys, HCys, Leu,
- hydrophobic
- Ile, allylleucine,
- hydrophobic
- Ile, allylleucine,
- residue
- Val, allylglycine,
- residue
- Val, allylglycine,
- Thr,
- Thr,
- selenocysteine,
- selenocysteine,
- hexafluoroleucine,
- hexafluoroleucine,
- hexafluorovaline
- hexafluorovaline
- (or analogue of
- (or analogue of
- any of the
- any of the
- preceding
- preceding
- residues)
- residues)
- eX7
- any residue
- Phe, Tyr, Trp,
- eX′6
- modified or
- Phe
- azidolysine, Cys
- unmodified
- Phe and
- analogues
- thereof
- fX8
- any
- Gln, Glu
- fX′7
- any
- Gln, Arg
- negatively
- positively
- charged
- charged
- residue,
- residue,
- modified or
- modified or
- unmodified
- unmodified
- Gln and
- Gln and
- analogues
- analogues
- thereof
- thereof
- gX9
- modified or
- QCy
- gX′8
- azidolysine
- azidolysine, Glu,
- unmodified
- and
- Arg
- QCy and
- analogues
- analogues
- thereof,
- thereof
- modified or
- unmodified
- Glu and
- analogues
- thereof,
- modified or
- unmodified
- Arg and
- analogues
- thereof
- aX10
- any
- Cys, HCys, Leu,
- aX′9
- any
- Cys, HCys, Leu,
- hydrophobic
- Ile, allylleucine,
- hydrophobic
- Ile, allylleucine,
- residue
- Val, allylglycine,
- residue
- Val, allylglycine,
- Thr,
- Thr,
- selenocysteine,
- selenocysteine,
- hexafluoroleucine,
- hexafluoroleucine,
- hexafluorovaline
- hexafluorovaline
- (or analogue of
- (or analogue of
- any of the
- any of the
- preceding
- preceding
- residues)
- residues)
- bX11
- any residue
- Asp, Arg
- bX′10
- modified or
- Asp
- unmodified
- Asp and
- analogues
- thereof
- cX12
- modified or
- Arg
- cX′11
- any
- Asn, Glu
- unmodified
- negatively
- Arg and
- charged
- analogues
- residue,
- thereof
- modified or
- unmodified
- Asn and
- analogues
- thereof
- dX13
- any
- Cys, HCys, Leu,
- dX′12
- any
- Cys, HCys, Leu,
- hydrophobic
- Ile, allylleucine,
- hydrophobic
- Ile, allylleucine,
- residue
- Val, allylglycine,
- residue
- Val, allylglycine,
- Thr,
- Thr,
- selenocysteine,
- selenocysteine,
- hexafluoroleucine,
- hexafluoroleucine,
- hexafluorovaline
- hexafluorovaline
- (or analogue of
- (or analogue of
- any of the
- any of the
- preceding
- preceding
- residues)
- residues)
- eX14
- azidolysine
- azidolysine, Glu,
- eX′13
- modifiedor
- Ile
- and
- Arg
- unmodified
- analogues
- Ile and
- thereof,
- analogues
- modified or
- thereof
- unmodified
- Glu and
- analogues
- thereof,
- modified or
- unmodified
- Arg and
- analogues
- thereof
- fX′14
- modified or
- Arg
- unmodified
- Arg and
- positively
- charged
- analogues
- thereof
(canceled)
Dependencies are inferred from the claim text.